EXAS — Exact Sciences Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousLarge CapNeutral

Annual income statement for Exact Sciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	R2020 December 31st	2021 December 31st	C2022 December 31st	C2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	1,491	1,767	2,084	2,500	2,759
Cost of Revenue
Gross Profit	1,137	1,308	1,423	1,762	1,919
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	2,259	2,623	2,678	2,704	3,797
Operating Profit	-768	-856	-594	-205	-1,038
Total Net Non Operating Interest Income / Expense
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes	-829	-843	-633	-202	-1,036
Provision for Income Taxes
Net Income After Taxes	-824	-596	-624	-204	-1,029
Net Income Before Extraordinary Items
Net Income	-824	-596	-624	-204	-1,029
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-824	-596	-624	-204	-1,029
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-2.77	-3.08	-3.48	-1.17	-2.55